Cogent Biosciences Inc

COGTNASDAQ · US

Holders

REDUCEDStale
Morris Arlene
Cogent Biosciences Inc · NASDAQ
−42,349 sh · $1.6M
Filed 31 Aug 2026SEC Form 4view source
REDUCEDStale
Morris Arlene
Cogent Biosciences Inc · NASDAQ
−3,161 sh · $118.7K
Filed 31 Aug 2026SEC Form 4view source
ACQUIREDStale
Morris Arlene
Cogent Biosciences Inc · NASDAQ
+41,927 sh · $236.5K
Filed 31 Aug 2026SEC Form 4view source
ACQUIREDStale
Morris Arlene
Cogent Biosciences Inc · NASDAQ
+3,583 sh · $9.0K
Filed 31 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Cogent Biosciences Inc · NASDAQ
53,090 sh · $2.0M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Cogent Biosciences Inc · NASDAQ
706,268 sh · $27.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Duquesne Family Office
Cogent Biosciences Inc · NASDAQ
2,214,470 sh · $78.7M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Duquesne Family Office
Cogent Biosciences Inc · NASDAQ
1,059,580 sh · $15.2M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Cogent Biosciences Inc · NASDAQ
7,288,378 sh · $61.4M
Filed 30 Jun 2024SEC 13Fview source